Tertius News is an AI-native newsroom: an AI model reads the linked source articles below and extracts what each outlet reported, so you can compare their coverage side by side. How this works →

Ebola cases top 4,000 in DRC as WHO urges Ervebo vaccine trial

The Bundibugyo Ebola outbreak in the Democratic Republic of the Congo has exceeded 4,000 confirmed cases, according to government data, with the World Health Organization recommending a full-scale trial of the Ervebo vaccine to combat the strain. Efforts to develop a species-specific vaccine and improve treatment are underway, but experts caution that results are months away.

By Tertius News AI Desk 2 outlets · 2 articles Version 1 Coverage Aug 5–7, 2026 Published Aug 14

Lead

Ebola cases in the Democratic Republic of the Congo (DRC) have surpassed 4,000, according to government data, as the world’s second-largest outbreak shows no sign of slowing. The World Health Organization (WHO) has recommended a full-scale human trial of the only existing approved Ebola vaccine to see if it could offer cross-protection against the deadly Bundibugyo strain, for which there is currently no vaccine.

Coverage Comparison

Two outlets report different case counts, reflecting the evolving nature of the outbreak data. Al Jazeera cites the latest Ministry of Health situation report, which shows 4,053 Bundibugyo cases, including 1,850 deaths, since the outbreak was declared in mid-May. AllAfrica, citing WHO, reports 3,748 cases, including 1,657 deaths and 708 recoveries, as of 1 August.

Both sources agree on the severity of the outbreak. Al Jazeera describes it as the "fastest-spreading" on record, while AllAfrica notes it is the largest ever outbreak of this species. The epidemic has hit 53 health zones across five provinces: Ituri, North Kivu, South Kivu, Haut-Uele, and Tshopo, according to Al Jazeera. Eighty-seven percent of cases are in Ituri province, the epicentre, with 11 percent in neighbouring North Kivu.

Key Claims

The outbreak has surpassed 4,000 confirmed cases, per government data reported by Al Jazeera.
As of 1 August, WHO-reported figures stood at 3,748 cases, 1,657 deaths, and 708 recoveries, according to AllAfrica.
The outbreak spans 53 health zones across five provinces, with Ituri province accounting for 87% of cases.
The WHO has recommended a full-scale human trial of the Ervebo vaccine to test cross-protection against the Bundibugyo strain.
Ervebo has proven safe and efficacious against the more common Zaire strain of Ebola.
Trials for the first Bundibugyo species-specific candidate vaccine began in the UK on 24 July, with a second starting in Canada this week.
A new 100-bed treatment centre was inaugurated in Bunia, capital of Ituri.
The UN refugee agency, UNHCR, is supporting screening, infection prevention, and risk communication efforts.

Vaccine and Treatment Efforts

AllAfrica reports that trials for the first ever Bundibugyo species-specific candidate vaccine began in the UK on 24 July, with a second starting in Canada this week. Both trials are being conducted on ferrets and monkeys, after which results would be analysed by WHO before deciding on whether to move to the subsequent phase. Vasee Moorthy, acting lead of WHO's R&D Blueprint, said that compared to previous outbreaks, trials started more quickly this time because protocols had been written before the current outbreak was declared.

Clinical trials of medicine and treatment options are also rolling out in Ituri province, the restive epicentre of the outbreak. A new 100-bed treatment centre was inaugurated in Bunia, capital of Ituri, according to AllAfrica. The UN refugee agency, UNHCR, is supporting screening, infection prevention, risk communication and provision of essential hygiene items.

Despite these efforts, there are still no proven safe and efficacious treatment, preventive or vaccination options for the Bundibugyo species, Dr. Moorthy told reporters in Geneva, as quoted by AllAfrica. He added that it would likely still be several months before more definite conclusions could be drawn from the ongoing trials.

Al Jazeera notes that the disease response has faced challenges including the country's military conflict, delayed detection and a lack of readily available treatments and vaccines. The epidemic has been described as the fastest-spreading on record, and experts quoted by Al Jazeera believe the true number of cases may be much higher than the official tally.

Perspectives

WHO

The World Health Organization is facilitating research and development efforts, recommending a full-scale trial of the Ervebo vaccine to test cross-protection against the Bundibugyo strain. WHO officials emphasise the need for more data before conclusions can be drawn, and express cautious optimism about the accelerated pace of trials.

DRC Ministry of Health

The DRC Ministry of Health, cited by Al Jazeera, reports the official case and death figures, providing the data that underlines the scale of the outbreak. The ministry's situation reports are a key source of information, though experts suggest the true number of cases may be higher.

How each outlet told it

Al Jazeera as of Aug 7, 2026, 9:00 PM UTC

Framing: Fastest-spreading Ebola outbreak on record — Urgent and concerned

Facts Included:

4,053 Bundibugyo cases in DRC
1,850 deaths in DRC
53 health zones affected across five provinces
87% of cases in Ituri province
WHO recommended full-scale human trial of Ervebo vaccine
Ervebo vaccine shown to be safe and efficacious against Zaire strain
Potential for Ervebo to offer cross-protection against Bundibugyo strain

Read the source article →

AllAfrica as of Aug 5, 2026, 5:30 AM UTC

Framing: Efforts advancing towards treatment and vaccine — Informative and hopeful

Facts Included:

3,748 cases and 1,657 deaths as of 1 August
Trials for Bundibugyo species-specific vaccine began in UK and Canada
New 100-bed treatment centre inaugurated in Bunia
UN refugee agency supporting screening and infection prevention
Clinical trials of medicine and treatment options rolling out in Ituri province

Read the source article →

What was claimed, and who backed it

Each row is one claim, attributed to the outlet whose wording states it most clearly. Confidence rates how directly the source text states the claim — explicit and unhedged rates high; hedged, pieced-together, or internally inconsistent statements rate lower. It does not measure whether the claim is true. Status counts the distinct outlets we found asserting it — so a single-source claim can still show high confidence, and a multi-source claim can show medium. Every one of those outlets is named beside the status, so you can check the count against the list. For claims extracted before we began storing that list, the row says so: it names the outlet the claim is quoted from and states that we have not recorded which outlets backed it. Outlets wrote at different times, so a figure that evolves — a casualty count, for example — can legitimately differ between rows; check the "as of" time next to each claim's source.

Claim	Confidence	Status
ClaimThe Bundibugyo epidemic in the Democratic Republic of the Congo has surpassed 4,000 confirmed cases. As of mid-May, DRC reported 4,053 Bundibugyo cases, including 1,850 deaths.	ConfidenceHigh	StatusContested via Al Jazeera as of Aug 7, 2026, 9:00 PM UTC
ClaimAs of 1 August, there were 3,748 cases, including 1,657 deaths and 708 recoveries, according to WHO.	ConfidenceHigh	StatusContested via AllAfrica as of Aug 5, 2026, 5:30 AM UTC
ClaimThe outbreak has hit 53 health zones across five provinces: Ituri, North Kivu, South Kivu, Haut-Uele, and Tshopo.	ConfidenceHigh	StatusSingle-source via Al Jazeera as of Aug 7, 2026, 9:00 PM UTC
ClaimEighty-seven percent of cases are in Ituri province, the epicentre of the current outbreak, with 11 percent in neighbouring North Kivu.	ConfidenceHigh	StatusSingle-source via Al Jazeera as of Aug 7, 2026, 9:00 PM UTC
ClaimThe WHO recommended a full-scale human trial of the Ervebo vaccine to see if it could offer cross-protection against the deadly Bundibugyo strain spreading in DRC.	ConfidenceHigh	StatusMulti-source quoted from Al Jazeera as of Aug 7, 2026, 9:00 PM UTC the outlets behind this status were not recorded for this claim
ClaimErvebo has proven to be safe and efficacious against the more common Zaire strain of the Ebola virus.	ConfidenceHigh	StatusSingle-source via Al Jazeera as of Aug 7, 2026, 9:00 PM UTC
ClaimTrials for the first ever Bundibugyo species-specific candidate vaccine began in the UK on 24 July, with a second starting in Canada this week.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Aug 5, 2026, 5:30 AM UTC
ClaimA new 100-bed treatment centre was inaugurated in Bunia, capital of Ituri.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Aug 5, 2026, 5:30 AM UTC
ClaimThe UN refugee agency, UNHCR, is supporting screening, infection prevention, risk communication and provision of essential hygiene items.	ConfidenceHigh	StatusSingle-source via AllAfrica as of Aug 5, 2026, 5:30 AM UTC

Transparency & Audit Trail

2 outlets · 2 articles consulted: Al Jazeera, AllAfrica 9 claims extracted Version 1 Written 2026-08-14